SANTA CLARA, Calif.--(BUSINESS WIRE)--Sep. 5, 2014--
Agilent Technologies Inc. (NYSE: A) today announced the following
webcast for the investment community:
Morgan Stanley Healthcare Conference
Tuesday, Sept. 9, at
12:55 p.m. EDT
Grand Hyatt, New York, N.Y.
Mike McMullen,
president, Chemical Analysis Group
A link to the webcast will be available at www.investor.agilent.com.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a leader in chemical analysis,
life sciences, diagnostics, electronics and communications. The
company’s 20,600 employees serve customers in more than 100 countries.
Agilent had revenues of $6.8 billion in fiscal 2013. Information about
Agilent is available at www.agilent.com.
In September 2013, Agilent announced plans to separate into two publicly
traded companies through a tax-free spinoff of its electronic
measurement business. On Aug. 1, 2014, the company’s electronic
measurement business began operating as Keysight Technologies, Inc., a
wholly owned subsidiary. The separation is expected to be completed in
early November 2014.
Forward-Looking Statements
This news release contains forward-looking statements as defined in the
Securities Exchange Act of 1934 and is subject to the safe harbors
created therein. The forward-looking statements contained herein
include, but are not limited to, information regarding the separation of
Agilent’s electronic measurement business; future revenues, earnings and
profitability; the future demand for the company’s products and
services; and customer expectations. These forward-looking statements
involve risks and uncertainties that could cause Agilent’s results to
differ materially from management’s current expectations. Such risks and
uncertainties include, but are not limited to, unforeseen changes in the
strength of our customers’ businesses; unforeseen changes in the demand
for current and new products, technologies, and services; customer
purchasing decisions and timing, and the risk that we are not able to
realize the savings expected from integration and restructuring
activities.
In addition, other risks that Agilent faces include those detailed in
Agilent’s filings with the Securities and Exchange Commission, including
our latest Form 10-K and Form 10-Q. Forward-looking statements are based
on the beliefs and assumptions of Agilent’s management and on currently
available information. Agilent undertakes no responsibility to publicly
update or revise any forward-looking statement.
NOTE TO EDITORS: Further technology, corporate citizenship and executive
news is available at www.agilent.com/go/news.
Source: Agilent Technologies Inc.
INVESTOR CONTACT:
Agilent Technologies Inc.
Alicia Rodriguez,
+1 408-345-8948
alicia_rodriguez@agilent.com